Aardvark Therapeutics, Inc. (AARD)

1.35 +0.18 (+15.38%) USD  |  NASDAQ  |  Nov 09, 12:08
More

Aardvark Therapeutics EV to Revenues

EV to Revenues Chart

View EV to Revenues for AARD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EV to Revenues Data

View and export this data back to . Start Trial.
Date Value

EV to Revenues Range, Past 5 Years

View EV to Revenues Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EV to Revenues Benchmarks

View EV to Revenues Benchmarks
Start Trial
Johnson & Johnson Upgrade
Bristol Myers Squibb Co. Upgrade
ANI Pharmaceuticals, Inc. Upgrade
Corcept Therapeutics, Inc. Upgrade
Veru, Inc. --

EV to Revenues Related Metrics

EV to CFO Upgrade
EV to Free Cash Flow Upgrade
EV to Assets (Quarterly) Upgrade
EV to Earnings Upgrade